Brought to you by 
Huadong Medicine licenses rights to MediBeacon's kidney function monitoring system; Agreement amended
27 Jan 2023
Executive Summary
MediBeacon Inc. granted Huadong Medicine Co. Ltd. exclusive rights to develop and sell its Transdermal Glomerular Filtration Rate (TGFR) measurement system in 25 Asian countries including China, Hong Kong, Macau, Taiwan, Thailand, Vietnam, Indonesia, Philippines, and Singapore.
Deal Industry
- Medical Devices
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
Medical Devices
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Huadong Medicine licenses rights to MediBeacon's kidney function monitoring system; Agreement amended
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice